Project Details
Description
MT2024-Phase 1 Study of FT522 in B-cell Mediated Autoimmune Diseases
| Status | Active |
|---|---|
| Effective start/end date | 2/4/25 → 2/3/36 |
Funding
- FATE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.